Immunogenetics of the Neonatal Lupus Syndrome
- LELA A. LEE, M.D.;
- WILMA B. BIAS, Ph.D;
- FRANK C. ARNETT, Jr., M.D.;
- J. CLARK HUFF, M.D.;
- DAVID A. NORRIS, M.D.;
- CATHERINE HARMON, M.D.;
- THOMAS T. PROVOST, M.D.; and
- WILLIAM L. WESTON, M.D.
Abstract
Infants with neonatal lupus erythematosus have congenital heart block, transient cutaneous lesions, or both. Mothers of these infants have SSA/Ro autoantibodies that are passed across the placenta to the fetus and that have been temporarily associated with the syndrome. Six families with neonatal lupus were studied by HLA typing. All seven infants had transient cutaneous lesions, congenital heart block, or both. Five of six mothers were asymptomatic and one had Sjögren's syndrome. Six of seven infants and all six mothers had antibodies to SSA/Ro in their sera. The infants became seronegative by age 8 months. Five mothers were positive for HLA-DR3, five for HLA-MB2, six for HLA-MT2, and six for HLA-B8. No HLA associations were seen in infants. Gene products of the DR or similar regions may be associated with autoantibody production but not with other events in tissue injury.
Article and Author Information
-
▸From the Departments of Dermatology and Internal Medicine, University of Colorado School of Medicine, Denver, Colorado; and the Departments of Dermatology and Internal Medicine, The Johns Hopkins University Medical School, Baltimore, Maryland.
-
▸Requests for reprints should be addressed to Lela A. Lee, M.D.; Dermatology Department B-153, University of Colorado Medical Center, 4200 East Ninth Avenue; Denver, CO 80262.
- ©1983 American College of Physicians
RSS Feeds









